|Organic compounds -- part of the class 532-570 series patents - Monitor Patents|
USPTO Class 536 | Browse by Industry: Previous - Next | All
Recent | 13: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | 12: Dec | Nov | Oct | Sep | Aug | July | June | May | April | Mar | Feb | Jan | 11: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | 10: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | | 09: Dec | Nov | Oct | Sep | Aug | Jl | Jn | May | Apr | Mar | Fb | Jn | | 2008 | 2007 |
Organic compounds -- part of the class 532-570 seriesBelow are recently published patent applications awaiting approval from the USPTO. Recent week's RSS XML file available below.
Listing for abstract view: USPTO application #, Title, Abstract excerpt,Patent Agent. Listing format for list view: USPTO National Class full category number, title of the patent application. 02/27/2014 > 5 patent applications in 5 patent subcategories.
20140058074 - Use of 3,8,12,14, 17,20-oxo-substituted pregnene glycosides in the preparation of healthcare products, food additives and pharmaceuticals for the inhibition of appetite: The present invention relates to the use of 3,8,12,14,17,20-oxo-substituted pregnene glycosides having the following formula I in the preparation of healthcare products, food additives and drugs for losing body weight, controlling body weight and inhibiting appetite of human beings or animals, wherein, R1 is a saccharide group, and R2 is... Agent: Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences
20140058075 - Nucleic acid sequences encoding sece/sec61-gamma subunits of protein translocation complexes: Isolated polynucleotides and polypeptides encoded thereby are described, together with the use of those products for making transgenic plants.... Agent: Ceres, Inc.
20140058076 - 5-position modified pyrimidines and their use: The present disclosure relates to the field of nucleic acid chemistry, specifically to 5-position modified uridines as well as phosphoramidite and triphosphate derivatives thereof. The present disclosure also relates to methods of making and using the same.... Agent:
20140058077 - Method for fabricating fiber products and composites: Method for fabricating fiber and film products and composites includes: introducing an aqueous gel of nanofibrillar cellulose into a volume of organic extraction agent miscible with water so that the aqueous gel is kept as a separate phase and forms one or several discrete physical entities containing the nanofibrillar cellulose... Agent: Upm-kymmene Corporation
20140058078 - Polyrotaxane composition: The present invention aims to provide a polyrotaxane composition having excellent storage stability. The present invention relates to a polyrotaxane composition comprising: a polyrotaxane containing a cyclodextrin, a polyethylene glycol which is included in the cavities of the cyclodextrin molecules in a skewered manner, and a capping group that is... Agent: Sumitomo Seika Chemicals Co., Ltd.02/20/2014 > 8 patent applications in 8 patent subcategories.
20140051843 - Methods and compositions for detecting promoter activity and expressing fusion proteins: The present invention provides nucleic acid molecules comprising one or more nucleic acid sequences encoding a polypeptide having a detectable activity. The present invention also provides methods of joining such nucleic acid molecules to nucleic acid molecules to be assayed for promoter activity. The present invention also relates to methods... Agent: Life Technologies Corporation
20140051844 - Nucleic acid purification: Methods and composition for nucleic acid isolation are provided. In one embodiment, a method is provided for nucleic acid purification from biological samples, such as whole blood samples, extracted with phenol-based denaturing solvents, which does not require phase separation or nucleic acid precipitation. Methods according to the invention may also... Agent:
20140051845 - Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol): The invention provides for preparing a polymer-active agent conjugate, the method comprising the steps of reacting an amino acid derivative with a biologically active agent under conditions to form a polymer-active agent conjugate.... Agent: Nektar Therapeutics
20140051846 - 2'-o-aminooxymethyl nucleoside derivatives for use in the synthesis and modification of nucleosides, nucleotides and oligonucleotides: Disclosed are O-protected compounds of the formula (I): wherein B is an optionally protected nucleobase, and R1-R3 are as described herein, a method of preparing such compounds, and a method of preparing oligonucleotides such as RNA starting from such compounds. The O-protected compounds have one or more advantages, for example,... Agent: Theunited Ofamerica,asrepresentedbythe Secre -tary,department Ofhealthand Human Service
20140051847 - Method for isolating dna: The present invention provides a method for the isolation of nucleic acid from microbial cells in an environmental sample. The method includes preparing a suspension of the environmental sample, lysing the suspended sample with a buffered solution, adding sodium dodecylsulfate solution to the lysed suspended sample, carrying out solvent extraction... Agent: Universiti Putra Malaysia
20140051848 - Nucleotides and nucleosides and methods for their use in dna sequencing: The present invention relates generally to labeled and unlabeled cleavable terminating groups and methods for DNA sequencing and other types of DNA analysis. More particularly, the invention relates in part to nucleotides and nucleosides with chemically cleavable, photocleavable, enzymatically cleavable, or non-photocleavable groups and methods for their use in DNA... Agent:
20140051849 - Hemostatic compositions and therapeutic regimens: The present invention relates generally to the field of hemostasis, including methods, compositions, and devices that can be employed to treat wounds. More specifically the present invention relates to hemostatic compositions that reduce the need for, and cost of, nursing care of patients with chronic wounds by reducing the frequency... Agent: Marine Polymer Technologies, Inc.
20140051850 - Lactose crystallisation: The invention relates to a method of crystallising lactose from a lactose-containing liquid comprising the steps of providing a lactose-containing liquid comprising less than 80% by weight total solids, providing an evaporator system that comprises a heat exchanger and an evaporation vessel, the heat exchanger comprising a tube or tubes... Agent:02/13/2014 > 10 patent applications in 9 patent subcategories.
20140046043 - C-4\" position substituted macrolide derivative: A macrolide compound represented by the formula (I) effective against erythromycin resistant bacteria (for example, resistant pneumococci, streptococci and mycoplasmas).... Agent: Taisho Pharmaceutical Co., Ltd.
20140046044 - Novel glycosyl phosphites: m
20140046045 - Method for preparing precursor used for labeling hepatocyte receptor and containing trisaccharide and dtpa ligand: A method for preparing a precursor used to label hepatocyte receptors is revealed. The precursor contains a bifunctional structure including trisaccharide and DTPA ligand. During synthesis processes of the precursor, silica gel columns and Reverse phase-18 (RP-18) columns are used for purification. Thus both the purification times and cost of... Agent: Atomic Energy Council - Institute Of Nuclear Energy Research
20140046047 - Organ-specific gene, method for identifying the same and use thereof: The present invention provides a method of extracting an organ- or tissue-specific highly expressed gene, including: (1) a step for measuring expression level of a specified gene group for each organ or tissue in 2 or more individuals, (2) a step for acquiring (a) a minimum value of expression levels... Agent: Takeda Pharmaceutical Company Limited
20140046049 - Axmi-205 pesticidal gene and method for its use: Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions comprising a coding sequence for pesticidal polypeptides are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in plants and bacteria. Compositions also comprise... Agent: Athenix Corp.
20140046048 - Molecular standards for microbial pathogens: A method for constructing a consensus sequence from a sequence alignment. The consensus sequence may be used to generate molecular standards that may substitute for genomic DNA in various assays. Since a molecular standard cannot have unresolved bases, the method removes less informative sequences to resolve all positions in the... Agent: Phthisis Diagnostics LLC
20140046050 - Method for isolating nucleic acids and composition used therefor: The disclosure provides a composition and method for isolating nucleic acids, in which the composition includes at least one halocarbon, at least one salt and at least one surfactant. Mixing the composition and a biosample to form a homogenized solution, nucleic acids in the solution can be easily isolated with... Agent: Industrial Technology Research Institute
20140046051 - N-substituted mannosamine derivatives, process for their preparation and their use: A compound of the formula (1) wherein R1 is a group removable by hydrogenolysis, and wherein R2 is OH or R2 is —NHR3 wherein R3 is a group removable by hydrogenolysis. The compound can be made from fructose by a Heyns-rearrangement. The compound can be used then to make free... Agent: Glycom A/s
20140046052 - Therapeutic sulfated polysaccharides, compositions thereof, and methods for treating patients: Disclosed are methods and compositions for the treatment of a variety of disorders in subjects by affecting the glycocalyx of a subject in need of such treatment. The methods comprise administering to a subject an effective amount of a sulfated polysaccharide (SP) or analogue thereof, the SP being a non-animal... Agent:02/06/2014 > 11 patent applications in 10 patent subcategories.
20140039170 - Composition for topical skin application containing ginsenoside f2 derived from hydroponic ginseng: Beneficial effects are obtained by topically applying ginsenoside F2 to the skin to improve skin conditions, improve water content on the skin surface and related benefits improving skin problems associated with acne or atopy, providing a skin whitening effect, helping control of sebaceous secretion, tightening skin pores, or improving skin... Agent: Amorepacific Corporation
20140039171 - Novel macrolide intermediate and novel production process: Provided are: a novel monoalkylamino intermediate (I); and a production method for a compound represented by the formula (III), which is an animal antibacterial agent, via the novel monoalkylamino intermediate.... Agent: Meiji Seika Pharma Co., Ltd.
20140039172 - Devices and systems for isolating biomolecules and associated methods thereof: A device, a system, and a method for isolating biomolecules from biological materials are provided. The device comprises a quartz-based solid phase extraction matrix comprising one or more reagents impregnated therein; and an electroosmotic pump (EOP) operationally coupled to the quartz-based solid phase extraction matrix to elute the nucleic acids,... Agent: General Electric Company
20140039173 - Generation and reproduction of dna sequences and analysis of polymorphisms and mutations by using error-correcting codes: The present invention relates to a method that uses error-coding codes for validating polymorphisms and mutations/alterations in a DNA sequence which encodes a polypeptide sequence. The present invention also relates to a digital communication system for carrying out the method, employing a model for the biological coding system which resembles... Agent: State University Of Campinas
20140039174 - Ribonucleic acid binding motif protein 20 sequence variants: This document relates to methods and materials for using nucleic acid and amino acid sequence variants of ribonucleic acid binding motif protein 20 (RBM20). For example, methods and materials for using nucleic acid sequence variants and/or their corresponding amino acid variants of RBM20 that are associated with dilated cardiomyopathy to... Agent: Mayo Foundation For Medical Education And Research
20140039175 - Synthesis of deuterated ribo nucleosides, n-protected phosphoramidites, and oligonucleotides: The present invention is directed towards the synthesis of high purity deuterated sugars, deuterated phosphoramidites, deuterated nucleobases, deuterated nucleosides, deuterated oligonucleotides, and deuterated RNA's of defined sequences which can exhibit biochemically useful and biologically valuable properties, thus having potential for therapeutic uses.... Agent:
20140039176 - Methods and kits for extraction of dna: Methods and materials are disclosed for use in recovering a biopolymer from a solution. In particular, the invention provides methods for extraction and isolation of nucleic acids from biological materials. The nucleic acids can be separated by forming a stable complex with soluble polysaccharide polymers and magnetic particles, in the... Agent:
20140039177 - Methods of isolating nucleic acids under reduced degradation condition: A method of isolating nucleic acids from a biological material, comprises applying the biological material on a substrate comprising one or more cell lysis reagents impregnated therein; applying a fluid to the biological material applied on the substrate; extracting the nucleic acids from the biological material applied on the substrate;... Agent: General Electric Company
20140039178 - Synthesis of deuterated ribo nucleosides n-protected phosphoramidites, and oligonucleotides: The present invention is directed towards the synthesis of high purity deuterated sugars, deuterated phosphoramidites, deuterated nucleobases, deuterated nucleosides, deuterated oligonucleotides, and deuterated RNA's of defined sequences which can exhibit biochemically useful and biologically valuable properties, thus having potential for therapeutic uses.... Agent:
20140039179 - Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production: The invention is directed to processes of preparing phosphonate nucleosides comprising a phosphonalkoxy-substituted five-membered, saturated or unsaturated, oxygen-containing ring coupled to a heterocyclic nucleobase such as a pyrimidine or purine base. These compounds can be described by general formula (II)... Agent:
20140039180 - Mannose production from palm kernel meal using simulated moving bed separation: Disclosed is a process for the production of d-mannose from fermented palm oil kernel meal using a continuous SMB separation process. The process is useful for providing a simplified processing route to providing high purity d-mannose. The SMB process and the SMB cycle was operated to provide a high purity... Agent: Orochem Technologies, Inc.Previous industry: Organic compounds -- part of the class 532-570 series
Next industry: Organic compounds -- part of the class 532-570 series
RSS FEED for 20140227:
Integrate FreshPatents.com into your RSS reader/aggregator or website to track weekly updates.
For more info, read this article.
Thank you for viewing Organic compounds -- part of the class 532-570 series patents on the FreshPatents.com website. These are patent applications which have been filed in the United States. There are a variety ways to browse Organic compounds -- part of the class 532-570 series patent applications on our website including browsing by date, agent, inventor, and industry. If you are interested in receiving occasional emails regarding Organic compounds -- part of the class 532-570 series patents we recommend signing up for free keyword monitoring by email.
FreshPatents.com Support - Terms & Conditions
Results in 0.3236 seconds